Jaye Thompson

Dr. Thompson has over 30 years of experience in pharmaceutical and device product development. She is a co-founder, clinical advisor, and former Chief Operating Officer of Proxima Clinical Research, Inc. and a founder and former President of Synergos, Inc., both of which are clinical research service providers. Dr. Thompson previously served as Senior Vice President of Clinical and Regulatory Affairs and as a member of the board of directors of Repros Therapeutics, Inc., a reproductive health company. She also served as Senior Vice President of Clinical Development and Regulatory Affairs of Opexa Therapeutics, Inc., a multiple sclerosis cell therapy company, and as a senior clinical and regulatory leader at other clinical stage biotech companies and at inVentiv Clinical Solutions, LLC, a clinical research service provider. Dr. Thompson has advised several of the region’s leading life science companies on strategic and regulatory planning as well as clinical product development. She has directed and managed statistical analysis, data management, report writing, and the conduct of clinical trials for a wide variety of indications. Dr. Thompson has been actively involved in over 200 clinical trials for drugs, biologics, and devices, and she has been associated with numerous FDA regulatory submissions and represented sponsor companies at FDA meetings and advisory committee meetings. Dr. Thompson was appointed to the Governor’s Texas Emerging Technology Fund Advisory Committee. She received a BS in Applied Mathematics from Texas A&M University and an MS and a PhD in Biostatistics from the University of Texas Health Science Center in Houston.